Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

The effects of a new human leukocyte elastase inhibitor (recombinant guamerin) on cerulein-induced pancreatitis in rats

Authors
Jo, Yun JuChoi, Ho SoonJun, Dae WonLee, Oh YoungKang, Joo SeopPark, Il GyuJung, Kyung HwanHahm, Joon Soo
Issue Date
Jul-2008
Publisher
Elsevier BV
Keywords
leukocyte elastase inhibitor; guamerin; pancreatitis; interleukin-6; tumor necrosis factor-alpha
Citation
International Immunopharmacology, v.8, no.7, pp 959 - 966
Pages
8
Indexed
SCIE
SCOPUS
Journal Title
International Immunopharmacology
Volume
8
Number
7
Start Page
959
End Page
966
URI
https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/178215
DOI
10.1016/j.intimp.2008.02.014
ISSN
1567-5769
1878-1705
Abstract
Background: Pancreatic and neutrophil elastase can aggravate or induce acute pancreatitis. Although increased elastase levels in the plasma of pancreatitis patients and animal models have been reported, the mechanism by which elastase is involved in the pathogenesis of acute pancreatitis has not yet been elucidated. We aimed to investigate the effects and the possible mechanism of a new human leukocyte elastase inhibitor (recombinant guamerin) in the treatment of cerulein-induced acute pancreatitis in rats. Methods: Fifty Sprague-Dawley rats were divided into three groups: a saline-infused control group (I), a cerulein-induced acute pancreatitis group (II), and a cerulein plus guamerin infusion group (III). Guamerin (1-2 mu mol/kg/h) was infused continuously in group III. The severity of pancreatitis was determined biochemically, histologically, and by cytokine changes between groups I, II and III. Results: Significant differences in serum amylase, lipase, and pancreatic wet weight were observed in each group, respectively (group 1; 2346.2 IU/L, 9.9 IU/L, 1.4 +/- 0.3 g, group II; 13,596.8 IU/L, 7439.4 IU/L, 2.2 +/- 0.5 g, group III; 9443.2 IU/L, 4516.3 IU/L, 1.7 +/- 0.6 g). Serum IL-6 and TNF-alpha [AU1]level peaked 1-4 h and 1-2 h. After the induction of pancreatitis, IL-6 and TNF-alpha levels were decreased in group III than group 11, (group 1; 13.1/ 4.0 pg/mL, group II; 198.5/63.2 pg/mL, group III; 102.1/13.1 pg/mL), but no significant difference in IL-1 beta was observed. Histologic gradings and severity, such as vacuolization, inflammation, lobular disarray, and edema of the pancreas, were significantly tower in the cerulein plus guamerin infusion group III. Conclusions: Recombinant guamerin, a new human leukocyte elastase inhibitor, may decrease the severity of pancreatitis and diminish pancreatic acinar cell injury by inhibition of neutrophilic infiltration and cytokine activation in the initial stage of cerulein-induced acute pancreatitis in rats.
Files in This Item
Go to Link
Appears in
Collections
서울 의과대학 > 서울 진단검사의학교실 > 1. Journal Articles
서울 의과대학 > 서울 약리학교실 > 1. Journal Articles
서울 의과대학 > 서울 내과학교실 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Lee, Oh Young photo

Lee, Oh Young
서울 의과대학 (DEPARTMENT OF INTERNAL MEDICINE)
Read more

Altmetrics

Total Views & Downloads

BROWSE